| Name | Title | Contact Details |
|---|---|---|
Edoardo Mattei |
Chief Financial Officer and Corporate Secretary | Profile |
Hans Sommer |
Executive Vice President of Finance, RWB Michigan | Profile |
Margeaux Bruner |
Director of Diversity and Inclusion | Profile |
Brad Rogers |
Chief Executive Officer | Profile |
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
Peer Direct is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCapture is a Pittsford, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FYZICAL is the world`s fastest growing healthcare franchise, leading the charge to transform healthcare from one of “sick care” to “well care” by providing services focused on quality outcomes, total well-being, and prevention. FYZICAL provides business instruments allowing you to run your business more successfully and more profitably, immediately. Using a Nobel Prize winning formula, elite PTs, medical professionals, and business experts have created an innovative new business model which not only sets the standard for excellence in patient care, but also allows you to become the dominant provider of health care services in your community and secure a successful future. FYZICAL is effecting real change in healthcare by servicing a major unmet need in the patient population allowing independent business owners (financiers, PTs, Audiologists and Otolaryngologists) to experience emotional and financial rewards in the process.